[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356676-105":59,"doc-detail-356676-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluation-of-availability-and-affordability-of-lung-cancer-drugs-in-central-china-a-cross-sectional-study","Evaluation of availability and affordability of lung cancer drugs in Central China - a cross-sectional study","","Lung cancer causes the highest cancer-related morbidity and mortality in China, but drug accessibility remains uneven across patient populations. This cross-sectional study evaluates the availability and affordability of 23 lung cancer anticancer drugs in Central China. Using the WHO/HAI standardized approach across 62 hospitals (Dec 2022–Jul 2023), availability is measured by stocking proportions and affordability by treatment costs within 20% of household income, with supplemental procurement time to capture restocking dynamics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-availability-and-affordability-of-lung-cancer-drugs-in-central-china-a-cross-sectional-study/356676/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-availability-and-affordability-of-lung-cancer-drugs-in-central-china-a-cross-sectional-study/356676.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main purpose?","Question",{"text":112,"@type":113},"To investigate how available and affordable 23 lung cancer anticancer drugs were in Central China.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study measure drug availability and affordability?",{"text":117,"@type":113},"Availability was defined as the proportion of hospitals stocking medicines on the survey day, and affordability was assessed as treatment costs being within 20% of household income.",{"name":119,"@type":110,"acceptedAnswer":120},"What additional metric was introduced to evaluate availability dynamics?",{"text":121,"@type":113},"Supplemental procurement time (SPT) was used to measure restocking time for drugs that were unavailable on the survey day.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356676,1790218355,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Gao et al. BMC Health Services Research (2026) 26:575 BMC Health Services Research  \n[https://doi.org/10.1186/s12913-026-14368-7](https://doi.org/10.1186/s12913-026-14368-7)  \nRESEARCH Open Access  \nEvaluation of availability and affordability  of lung cancer drugs in Central China: a crosssectional study  \nSuyu Gao 1, Xuanxuan Wang 1 and Hong Cheng 1*  \nAbstract  \nPurpose Lung cancer remains the leading cause of cancer-related morbidity and mortality in China, yet systemic inequalities in drug accessibility persist. The present study aimed to investigate the availability and affordability of 23 anticancer drugs for lung cancer in Central China.  \nMethods A cross-sectional study was conducted from December 2022 to July 2023 across 62 hospitals in Central China using the WHO/HAI standardized methodology. Drug availability was defined as the proportion of hospitals stocking medicines on the survey day, while affordability was assessed as treatment costs ≤ 20% of household income. Supplemental procurement time (SPT) measuring restocking time for unavailable drugs, was introduced to evaluate availability dynamics.  \nResults Only 34 . 8% of drugs met WHO availability thresholds (>80%) . Traditional chemotherapies (e. g., cisplatin, gemcitabine) showed high availability (> 80% in tertiary hospitals) but remained unaffordable for low-income households (e. g., docetaxel originator brands (OBs): 288 .62-374. 27% of monthly income) . Unlike conventional availability metrics, our SPT index revealed rapid restocking (≤ 72 h) for 69.4% of anlotinib-a dynamic accessibility dimension previously unmeasured in oncology drug studies. Whereas crizotinib faced delays (> 1 month) in 43. 55% of hospitals, undetected by traditional methods.  \nConclusion We found that the availability of anticancer drugs for lung cancer is extremely unequal, and only a few medicines were considered affordable. Further efforts should be made to sufficiently and equally benefit patients with cancer.  \nKeywords Availability, Affordability, Anticancer medicines, Central China  \n*Correspondence:  \nHong Cheng  \n[chenghong@znhospital.cn](chenghong@znhospital.cn)  \n1Department of Pharmacy, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuchang District, Wuhan 430071, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nGao et al. BMC Health Services Research (2026) 26:575  \nIntroduction  \nGlobally, lung cancer causes approximately 2.2 million new cases and 1.8 million deaths annually [1, 2]. In China, it is the most prevalent malignancy, with an estimated 815,563 new cases and 714,699 deaths reported in 2022, representing nearly 40% of global lung cancerrelated mortality [3, 4]. At present, anticancer medicine is a core component of treatment, but barriers to receiving cancer therapy such as high price of anticancer medicines and poor access were yet to be solved. These problems may be related to medical information asymmetry and the distribution o","cbCairXdED605JMq","https://ap.wps.com/l/cbCairXdED605JMq","pdf",1986402,12,"English","# Abstract\n# Introduction\n# Methods\n## Study design and sample","[{\"question\":\"What was the study’s main purpose?\",\"answer\":\"To investigate how available and affordable 23 lung cancer anticancer drugs were in Central China.\"},{\"question\":\"How did the study measure drug availability and affordability?\",\"answer\":\"Availability was defined as the proportion of hospitals stocking medicines on the survey day, and affordability was assessed as treatment costs being within 20% of household income.\"},{\"question\":\"What additional metric was introduced to evaluate availability dynamics?\",\"answer\":\"Supplemental procurement time (SPT) was used to measure restocking time for drugs that were unavailable on the survey day.\"}]","Evaluation of availability and affordability of lung cancer drugs in Central China - a cross-sectional study | PDF",1790126762,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/492839849040c934f01090ea9f018961.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6d2a6c396384013ef000bc350375c89.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c16a2236c4e016b8e6a4404ee25036d6.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f98e2e8544fe7d04b39cc7762e206e1f.webp",980,1306]